Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

✍ Scribed by Davies, M.; Heller, S.; Sreenan, S.; Sapin, H.; Adetunji, O.; Tahbaz, A.; Vora, J.

• Book ID: 120677617
• Publisher: American Diabetes Association
• Year: 2012
• Tongue: English
• Weight: 223 KB
• Volume: 36
• Category: Article
• ISSN: 0149-5992
• DOI: 10.2337/dc12-1333